Insider Trades82 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Sell | IFF | Marc Birenkrant | Controller & CAO | 141 | $70.09 | $20.0B | -7.40% | +32.23% | $9.9K | -2.43% | — | Stalk |
| May 4, 2026 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 362 | $70.09 | $20.0B | -7.40% | +32.23% | $25.4K | -1.43% | — | Stalk |
| May 4, 2026 | Sell | IFF | Michael Deveau | EVP, CFO | 452 | $70.09 | $20.0B | -7.40% | +32.23% | $31.7K | -1.33% | — | Stalk |
| May 4, 2026 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 713 | $70.09 | $20.0B | -7.40% | +32.23% | $50.0K | -1.24% | — | Stalk |
| May 4, 2026 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 734 | $70.09 | $20.0B | -7.40% | +32.23% | $51.4K | -2.33% | — | Stalk |
| May 1, 2026 | Sell | IFF | Marc Birenkrant | Controller & CAO | 144 | $70.81 | $20.0B | -7.40% | +32.23% | $10.2K | -2.42% | — | Stalk |
| May 1, 2026 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 625 | $70.81 | $20.0B | -7.40% | +32.23% | $44.3K | -2.42% | — | Stalk |
| May 1, 2026 | Sell | IFF | Michael Deveau | EVP, CFO | 710 | $70.81 | $20.0B | -7.40% | +32.23% | $50.3K | -2.05% | — | Stalk |
| May 1, 2026 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 960 | $70.81 | $20.0B | -7.40% | +32.23% | $68.0K | -1.64% | — | Stalk |
| May 1, 2026 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 1,098 | $70.81 | $20.0B | -7.40% | +32.23% | $77.7K | -3.36% | — | Stalk |
| May 1, 2026 | Sell | IFF | Yuvraj Arora | President, Taste & CCO | 1,828 | $70.81 | $20.0B | -7.40% | +32.23% | $129.4K | -4.06% | — | Stalk |
| May 1, 2026 | Sell | IFF | J Erik Fyrwald | Chief Executive Officer | 7,763 | $70.81 | $20.0B | -7.40% | +32.23% | $549.7K | -3.28% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Marc Birenkrant | Controller & CAO | 171 | $72.57 | $20.0B | -7.40% | +32.23% | $12.4K | -1.99% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Andres Roberto Muller | President, Food Ingredients | 759 | $72.57 | $20.0B | -7.40% | +32.23% | $55.1K | -1.56% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 819 | $72.57 | $20.0B | -7.40% | +32.23% | $59.4K | -0.97% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 868 | $72.57 | $20.0B | -7.40% | +32.23% | $63.0K | -1.66% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 932 | $72.57 | $20.0B | -7.40% | +32.23% | $67.6K | -1.83% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Stephen N Landsman | EVP, General Counsel | 1,164 | $72.57 | $20.0B | -7.40% | +32.23% | $84.5K | -1.80% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Yuvraj Arora | President, Taste & CCO | 2,203 | $72.57 | $20.0B | -7.40% | +32.23% | $159.9K | -2.72% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Michael Deveau | EVP, CFO | 2,418 | $72.57 | $20.0B | -7.40% | +32.23% | $175.5K | -3.81% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | Leticia Goncalves Lourenco | President, Health & Bioscience | 3,243 | $72.57 | $20.0B | -7.40% | +32.23% | $235.3K | -2.94% | — | Stalk |
| Apr 1, 2026 | Sell | IFF | J Erik Fyrwald | Chief Executive Officer | 8,835 | $72.57 | $20.0B | -7.40% | +32.23% | $641.2K | -2.21% | — | Stalk |
| Mar 12, 2026 | Buy | IFF | J Erik Fyrwald | Chief Executive Officer | 14,260 | $69.79 | $20.0B | -7.40% | +32.23% | $995.2K | +9.16% | — | Stalk |
| Jan 2, 2026 | Sell | IFF | Andres Roberto Muller | President, Food Ingredients | 633 | $68.03 | $20.0B | -7.40% | +32.23% | $43.1K | -4.79% | — | Stalk |
| Dec 12, 2025 | Buy | IFF | Stephen N Landsman | EVP, General Counsel | 3,100 | $63.48 | $20.0B | -7.40% | +32.23% | $196.8K | +25.83% | — | Stalk |
| Dec 1, 2025 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 5,214 | $69.27 | $20.0B | -7.40% | +32.23% | $361.2K | -16.38% | — | Stalk |
| Sep 2, 2025 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 7,050 | $66.55 | $20.0B | -7.40% | +32.23% | $469.2K | -5.74% | — | Stalk |
| Aug 7, 2025 | Buy | IFF | J Erik Fyrwald | Chief Executive Officer | 15,300 | $64.95 | $20.0B | -7.40% | +32.23% | $993.7K | +24.65% | — | Stalk |
| Jun 2, 2025 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 329 | $75.71 | $20.0B | -7.40% | +32.23% | $24.9K | -10.65% | — | Stalk |
| May 19, 2025 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 2,400 | $77.33 | $20.0B | -7.40% | +32.23% | $185.6K | -41.95% | — | Stalk |
| May 19, 2025 | Buy | IFF | Stephen N Landsman | EVP, General Counsel | 12,000 | $77.28 | $20.0B | -7.40% | +32.23% | $927.4K | +120.00% | — | Stalk |
| May 8, 2025 | Buy | IFF | J Erik Fyrwald | Chief Executive Officer | 25,000 | $73.97 | $20.0B | -7.40% | +32.23% | $1.8M | +33.40% | — | Stalk |
| May 1, 2025 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 651 | $78.46 | $20.0B | -7.40% | +32.23% | $51.1K | -2.08% | — | Stalk |
| May 1, 2025 | Sell | IFF | Michael Deveau | EVP, CFO | 1,162 | $78.36 | $20.0B | -7.40% | +32.23% | $91.0K | -2.72% | — | Stalk |
| May 1, 2025 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 1,576 | $78.48 | $20.0B | -7.40% | +32.23% | $123.7K | -4.84% | — | Stalk |
| May 1, 2025 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 1,690 | $78.37 | $20.0B | -7.40% | +32.23% | $132.4K | -2.56% | — | Stalk |
| May 1, 2025 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 2,105 | $78.41 | $20.0B | -7.40% | +32.23% | $165.0K | -1.82% | — | Stalk |
| May 1, 2025 | Sell | IFF | J Erik Fyrwald | Chief Executive Officer | 8,105 | $77.85 | $20.0B | -7.40% | +32.23% | $631.0K | -6.08% | — | Stalk |
| May 1, 2025 | Sell | IFF | Yuvraj Arora | President, Taste & CCO | 10,682 | $78.93 | $20.0B | -7.40% | +32.23% | $843.1K | -12.35% | — | Stalk |
| Apr 4, 2025 | Sell | IFF | Michael Deveau | CFO | 719 | $73.12 | $20.0B | -7.40% | +32.23% | $52.6K | -1.57% | — | Stalk |
| Apr 4, 2025 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 809 | $73.12 | $20.0B | -7.40% | +32.23% | $59.2K | -3.03% | — | Stalk |
| Apr 4, 2025 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 2,545 | $73.12 | $20.0B | -7.40% | +32.23% | $186.1K | -4.18% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 15 | $79.79 | $20.0B | -7.40% | +32.23% | $1.2K | -1.58% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 34 | $79.79 | $20.0B | -7.40% | +32.23% | $2.7K | -0.39% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | Michael Deveau | CFO | 42 | $79.79 | $20.0B | -7.40% | +32.23% | $3.4K | -0.51% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | Jennifer Amy Johnson | EVP, General Counsel | 77 | $79.79 | $20.0B | -7.40% | +32.23% | $6.1K | -1.05% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | Simon Herriott | Pres. Health & Bioscience | 86 | $79.79 | $20.0B | -7.40% | +32.23% | $6.9K | -0.79% | — | Stalk |
| Mar 4, 2025 | Sell | IFF | Deborah Borg | EVP, Chief Ppl&Culture Officer | 123 | $79.79 | $20.0B | -7.40% | +32.23% | $9.8K | -0.52% | — | Stalk |
| Mar 4, 2025 | Buy | IFF | J Erik Fyrwald | CEO | 25,000 | $80.24 | $20.0B | -7.40% | +32.23% | $2.0M | +581.40% | — | Stalk |
| Jan 15, 2025 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 1,340 | $84.17 | $20.0B | -7.40% | +32.23% | $112.8K | -22.67% | — | Stalk |
| Dec 2, 2024 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 1,943 | $91.27 | $20.0B | -7.40% | +32.23% | $177.3K | -6.70% | — | Stalk |
| Nov 11, 2024 | Sell | IFF | Yuvraj Arora | President, Nourish | 5,000 | $91.75 | $20.0B | -7.40% | +32.23% | $458.8K | -60.69% | — | Stalk |
| Oct 3, 2024 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 389 | $100.63 | $20.0B | -7.40% | +32.23% | $39.1K | -3.72% | — | Stalk |
| Oct 1, 2024 | Sell | IFF | Glenn R Richter | CFO | 5,122 | $103.12 | $20.0B | -7.40% | +32.23% | $528.2K | -9.74% | — | Stalk |
| Sep 3, 2024 | Sell | IFF | Deborah Borg | EVP, Chief HR and D&I Officer | 7,049 | $103.58 | $20.0B | -7.40% | +32.23% | $730.1K | -5.46% | — | Stalk |
| Jul 3, 2024 | Sell | IFF | Simon Herriott | Pres. Health & Bioscience | 289 | $95.02 | $20.0B | -7.40% | +32.23% | $27.5K | -1.26% | — | Stalk |
| Jun 13, 2024 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 5,176 | $86.41 | $20.0B | -7.40% | +32.23% | $447.3K | +0.00% | — | Stalk |
| May 3, 2024 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 329 | $86.64 | $20.0B | -7.40% | +32.23% | $28.5K | -2.11% | — | Stalk |
| May 3, 2024 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 342 | $86.64 | $20.0B | -7.40% | +32.23% | $29.6K | -3.17% | — | Stalk |
| May 3, 2024 | Sell | IFF | Simon Herriott | Pres. Health & Bioscience | 493 | $86.64 | $20.0B | -7.40% | +32.23% | $42.7K | -2.11% | — | Stalk |
| May 3, 2024 | Sell | IFF | De Mendonca Ana Paula Teles | President, Scent | 517 | $87.66 | $20.0B | -7.40% | +32.23% | $45.3K | -6.41% | — | Stalk |
| May 3, 2024 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 535 | $86.64 | $20.0B | -7.40% | +32.23% | $46.4K | -1.81% | — | Stalk |
| May 3, 2024 | Sell | IFF | Deborah Borg | EVP, Chief HR and D&I Officer | 713 | $86.64 | $20.0B | -7.40% | +32.23% | $61.8K | -1.19% | — | Stalk |
| May 3, 2024 | Sell | IFF | Jennifer Amy Johnson | EVP, General Counsel | 765 | $86.64 | $20.0B | -7.40% | +32.23% | $66.3K | -3.85% | — | Stalk |
| May 3, 2024 | Sell | IFF | Glenn R Richter | CFO | 1,530 | $86.64 | $20.0B | -7.40% | +32.23% | $132.6K | -2.83% | — | Stalk |
| May 3, 2024 | Sell | IFF | Yuvraj Arora | President, Nourish | 3,300 | $86.64 | $20.0B | -7.40% | +32.23% | $285.9K | -8.34% | — | Stalk |
| Apr 5, 2024 | Sell | IFF | Jennifer Amy Johnson | EVP, General Counsel | 350 | $83.34 | $20.0B | -7.40% | +32.23% | $29.2K | -1.95% | — | Stalk |
| Apr 5, 2024 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 354 | $83.34 | $20.0B | -7.40% | +32.23% | $29.5K | -1.89% | — | Stalk |
| Apr 5, 2024 | Sell | IFF | Simon Herriott | Pres. Health & Biosci. & Scent | 494 | $83.34 | $20.0B | -7.40% | +32.23% | $41.2K | -2.03% | — | Stalk |
| Apr 1, 2024 | Sell | IFF | Simon Herriott | Pres. Health & Biosci. & Scent | 461 | $86.37 | $20.0B | -7.40% | +32.23% | $39.8K | -3.07% | — | Stalk |
| Mar 1, 2024 | Sell | IFF | Glenn R Richter | CFO | 46 | $75.88 | $20.0B | -7.40% | +32.23% | $3.5K | -0.26% | — | Stalk |
| Mar 1, 2024 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 48 | $75.88 | $20.0B | -7.40% | +32.23% | $3.6K | -0.68% | — | Stalk |
| Mar 1, 2024 | Sell | IFF | Jennifer Amy Johnson | EVP, General Counsel | 81 | $75.88 | $20.0B | -7.40% | +32.23% | $6.1K | -1.53% | — | Stalk |
| Mar 1, 2024 | Sell | IFF | Simon Herriott | Pres. Health & Biosci. & Scent | 104 | $75.88 | $20.0B | -7.40% | +32.23% | $7.9K | -1.49% | — | Stalk |
| Mar 1, 2024 | Sell | IFF | Frank Clyburn | Chief Executive Officer | 323 | $75.88 | $20.0B | -7.40% | +32.23% | $24.5K | -0.90% | — | Stalk |
| Jan 3, 2024 | Sell | IFF | Angela Strzelecki | President, Pharma Solutions | 478 | $79.99 | $20.0B | -7.40% | +32.23% | $38.2K | -4.51% | — | Stalk |
| Dec 15, 2023 | Buy | IFF | Beril Yildiz | CAO, SVP & Controller | 52.201 | $79.62 | $20.0B | -7.40% | +32.23% | $4.2K | +7.59% | — | Stalk |
| Dec 1, 2023 | Sell | IFF | Ralf Finzel | EVP, Global Operations Officer | 1,943 | $76.78 | $20.0B | -7.40% | +32.23% | $149.2K | -7.61% | — | Stalk |
| Nov 1, 2023 | Sell | IFF | Jennifer Amy Johnson | EVP, General Counsel | 376 | $68.06 | $20.0B | -7.40% | +32.23% | $25.6K | -3.18% | — | Stalk |
| Oct 3, 2023 | Sell | IFF | Beril Yildiz | CAO, SVP & Controller | 389 | $65.07 | $20.0B | -7.40% | +32.23% | $25.3K | -8.27% | — | Stalk |
| Oct 2, 2023 | Sell | IFF | Glenn R Richter | CFO | 6,031 | $65.97 | $20.0B | -7.40% | +32.23% | $397.9K | -12.52% | — | Stalk |
| Sep 1, 2023 | Sell | IFF | Deborah Borg | EVP, Chief HR and D&I Officer | 12,194 | $70.25 | $20.0B | -7.40% | +32.23% | $856.6K | -8.08% | — | Stalk |